Atlas Trials

Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

Clinical trial NCT03485495 · COMPLETED

Trial details

NCT number
NCT03485495
Sponsor
Materia Medica Holding
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cerebral Atherosclerosis
Start date
2018-04-12
Primary completion
2019-04-11
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.